CLINICAL TRIAL: CONGENITAL ADRENAL HYPERPLASIA: CALCIUM CHANNELS AS THERAPEUTIC

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究将测试降压药氨氯地平是否能够减少目前用于治疗CAH的糖皮质激素药物的剂量

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will test the ability of amlodipine, a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication currently taking to treat CAH